Shandong Xinhua Pharmaceutical Company Limited (XIN) — Free Cash Flow Generation Index
Shandong Xinhua Pharmaceutical Company Limited (XIN) has a Free Cash Flow Generation Index of -0.44x as of September 2023. Free cash flow of €-24.58 Million represents 0% of operating cash flow (€56.11 Million). See XIN current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shandong Xinhua Pharmaceutical Company Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Shandong Xinhua Pharmaceutical Company Limited across 13 annual periods. Explore debt repayment capacity of Shandong Xinhua Pharmaceutical Company L to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shandong Xinhua Pharmaceutical Company Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for Shandong Xinhua Pharmaceutical Company Limited. For the full company profile including market capitalisation, see XIN stock market capitalisation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | €418.13 Million | €533.73 Million | €115.60 Million | ▲ +85.6% |
| 2024 | 0.42x | €155.19 Million | €367.61 Million | €212.42 Million | ▲ +287.1% |
| 2023 | -0.23x | €-59.85 Million | €265.28 Million | €325.13 Million | ▼ -133.3% |
| 2022 | 0.68x | €513.48 Million | €758.24 Million | €244.76 Million | ▲ +1674.3% |
| 2021 | 0.04x | €9.89 Million | €259.12 Million | €249.23 Million | ▼ -88.5% |
| 2020 | 0.33x | €140.00 Million | €420.19 Million | €280.19 Million | ▲ +736.1% |
| 2019 | -0.05x | €-18.24 Million | €348.27 Million | €366.51 Million | ▲ +59.0% |
| 2018 | -0.13x | €-41.38 Million | €323.91 Million | €388.44 Million | ▼ -138.7% |
| 2017 | 0.33x | €128.86 Million | €389.97 Million | €261.11 Million | ▼ -78.2% |
| 2016 | 1.52x | €666.42 Million | €439.35 Million | €227.07 Million | ▲ +2.1% |
| 2015 | 1.48x | €517.72 Million | €348.64 Million | €169.09 Million | ▼ -15.2% |
| 2014 | 1.75x | €606.51 Million | €346.34 Million | €260.17 Million | ▼ -59.1% |
| 2013 | 4.28x | €449.52 Million | €104.99 Million | €344.53 Million | — |